2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7 Kemurnian ≥99,0% (HPLC) Pabrik Penengah Trelagliptin Succinate
Pasokan Komersial Trelagliptin Succinate Intermediate:
6-Chloro-3-Methyluracil CAS 4318-56-3
2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
Trelagliptin Succinate Intermediate-int D CAS 865759-24-6
Trelagliptin Succinate CAS 1029877-94-8
Please contact: alvin@ruifuchem.com
Jeneng Kimia | 2-Cyano-5-Flurobenzyl Bromide |
sinonim | 2-(Bromomethyl)-4-Fluorobenzonitrile |
Nomer CAS | 421552-12-7 |
Nomer CAT | RF-PI143 |
Status Simpenan | Ing Simpenan, Skala Produksi Nganti Ton |
Formula Molekul | C8H5BrFN |
Bobot Molekul | 214.03 |
Titik lebur | 67,0 kanggo 71,0 ℃ |
Sensitif | Kelembapan Sensitif |
Kelarutan | Larut ing Metanol |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Bubuk Putih nganti Kuning |
Kemurnian / Metode Analisis | ≥99,0% (HPLC) |
Kelembapan (KF) | ≤0,50% |
Sisa ing Ignition | ≤0,30% |
Impurity Tunggal | ≤0,50% |
Total Impurities | ≤1,00% |
1 H NMR Spektrum | Konsisten karo Struktur |
Standar Tes | Standar Perusahaan |
Panggunaan | Trelagliptin Succinate (CAS: 1029877-94-8) Menengah |
Paket: Botol, tas Aluminium foil, Drum karton, 25kg / Drum, utawa miturut kabutuhan pelanggan.
Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya, kelembapan lan infestasi hama.
![1](https://a395.goodao.net/uploads/15.jpg)
![2](https://a395.goodao.net/uploads/23.jpg)
Shanghai Ruifu Chemical Co., Ltd. minangka pabrikan lan pemasok 2-Cyano-5-Flurobenzyl Bromide (CAS: 421552-12-7) kanthi kualitas dhuwur, digunakake ing sintesis organik, sintesis intermediet farmasi lan bahan farmasi aktif. (API) sintesis.2-Cyano-5-Flurobenzyl Bromide bisa digunakake ing sintesis Trelagliptin Succinate (CAS: 1029877-94-8).Trelagliptin Succinate minangka inhibitor dipeptidyl peptidase-4 (DPP-4) sing selektif lan tumindak dawa.Agen antidiabetik.Inhibitor DPP-4 oral aktif sing ngasilake perbaikan sing signifikan sacara klinis lan statistik ing kontrol glikemik ing pasien diabetes tipe 2.Trelagliptin Succinate disetujoni kanggo digunakake ing Jepang ing Maret 2015.